Delivering 3 Strategic Leaders for an Immunology & Inflammation Biotech

A global biotech company specialising in Immunology and Inflammation was approaching a critical inflection point. With a pivotal clinical trial on the horizon and key investor activity expected around the JPM conference window, the organisation needed to rapidly strengthen its leadership capability across clinical, regulatory, and programme delivery functions.

These were crucial hires for the company. At a time when mistakes or delays might significantly affect timelines and investor confidence, each role would have a direct impact on cross-functional alignment, regulatory strategy, and trial execution.

The Requirement

We were engaged to deliver three senior leadership appointments:

• Senior VP, Clinical Operations
• Senior Director, Regulatory Affairs
• Senior Director, PMO

Each role required proven late-stage development experience, biotech operating exposure, and the ability to lead cross-functional delivery under tight timelines.

Delivery Metrics

We ran tightly targeted searches focused on directly relevant therapeutic and phase experience, presenting highly qualified shortlists rather than broad candidate pools.

Senior VP, Clinical Operations

• 6 candidates longlisted
• 3 progressed to interview
• Placement completed in 13 days

Senior Director, Regulatory Affairs

• 6 candidates longlisted
• 2 progressed to interview
• Offer secured in 10 days

Senior Director, PMO

• 10 candidates longlisted
• 6 progressed to interview
• Role filled in 24 days

Outcome

All three strategic hires were secured within compressed timelines ahead of key clinical and investor milestones. The strengthened leadership structure reduced delivery risk and supported trial and programme readiness at a pivotal stage for the organisation.

Reduce hiring risk at critical trial stages — partner with us to secure proven leadership talent.

https://www.barringtonjames.com/contact-us/